01—Abstract
Summary
Summary of the 8-K filed May 10, 2021. Cited figures are marked; the original filing is the authoritative source.
CME Group Inc. held its 2021 Annual Meeting of Shareholders on May 5, 2021, with a significant turnout of 82.51%a of outstanding shares represented.
The meeting's primary focus was on shareholder voting for various corporate matters, including director elections, ratification of the independent auditor, and advisory approval of executive compensation. All proposed items, including the election of 17 equity directors, the ratification of Ernst & Young LLP as auditor, and the advisory vote on executive compensation, received overwhelming support from Class A and Class B shareholders voting together. A notable outcome was the inability to achieve a quorum for the election of Class B-1 and Class B-3 directors.
Consequently, incumbent directors in these categories, William W. Hobert, Patrick J. Mulchrone, Robert J.
Tierney Jr. (Class B-1), and Elizabeth A. Cook (Class B-3), will continue to serve as "holdovers" until their successors are elected at the 2022 Annual Meeting or until their earlier resignation or removal. The election of Class B-2 directors did proceed, with two nominees elected.
02—Key points
Key Highlights
- High shareholder participation at the 2021 Annual Meeting, with 82.51% of outstanding shares represented.
- All 17 equity director nominees were elected by a substantial majority of Class A and Class B shareholders.
- The appointment of Ernst & Young LLP as the independent auditor for 2021 was ratified with overwhelming support.
- Shareholders provided advisory approval for the compensation of named executive officers.
- A quorum was not achieved for the election of Class B-1 and Class B-3 directors, resulting in 'holdover' directors.
- Incumbent directors for Class B-1 and Class B-3 will continue to serve until their successors are elected.
- Two Class B-2 directors were successfully elected from a slate of four nominees.
03—Questions
Frequently Asked Questions
What were the key outcomes of the CME Group 2021 Annual Meeting?
The key outcomes include the overwhelming election of 17 equity directors, the ratification of Ernst & Young LLP as the independent auditor, and advisory approval of executive compensation. However, a quorum was not met for the election of Class B-1 and Class B-3 directors, leading to 'holdover' directors in those positions.
Why will some directors continue to serve as 'holdovers'?
The 'holdover' status for certain Class B directors (B-1 and B-3) is due to a failure to achieve the necessary quorum for their election at the 2021 Annual Meeting. Under Delaware law and the company's bylaws, these directors will continue to serve until their successors are duly elected or they resign or are removed.
Were there any proposals that did not pass?
While all proposed items received significant shareholder support, the election of Class B-1 and Class B-3 directors did not achieve a quorum, meaning the elections for those specific seats were not successfully completed through the usual voting process.
How many shares were represented at the meeting?
A total of 296,276,223 shares of Class A and B common stock, representing 82.51% of the issued and outstanding shares, were present at the meeting, either in person or by proxy.
04—Continue